메뉴 건너뛰기




Volumn 18, Issue 1, 2012, Pages 34-40

The variety of types of adverse side-effects during treatment with biological drugs

Author keywords

Adverse side effects; Asthma; Biologics

Indexed keywords

ADALIMUMAB; ALEFACEPT; ALPHA INTERFERON; BETA INTERFERON; BEVACIZUMAB; BIOLOGICAL PRODUCT; CETUXIMAB; DENILEUKIN DIFTITOX; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 2; OMALIZUMAB; PALIVIZUMAB; RANIBIZUMAB; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; TRASTUZUMAB; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR INHIBITOR;

EID: 84863768859     PISSN: 12329142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (4)

References (22)
  • 1
    • 0035812751 scopus 로고    scopus 로고
    • Harnessing genomics and biotechnology to improve global health equity
    • DOI 10.1126/science.1062633
    • Singer P.A., Daar A.S.: Harnessing genomics and biotechnology to improve global health equity. Science, 2001; 294: 87-89. (Pubitemid 32952953)
    • (2001) Science , vol.294 , Issue.5540 , pp. 87-89
    • Singer, P.A.1    Daar, A.S.2
  • 4
    • 0242270743 scopus 로고    scopus 로고
    • Defining and characterizing the late-stage biopharmaceutical pipeline
    • Nagle P.C., Lugo T.F., Nicita C.A.: Defining and characterizing the late-state biopharmaceutical pipeline. Am. J. Manag. Care, 2003; 9(suppl): S124-35. (Pubitemid 37345200)
    • (2003) American Journal of Managed Care , vol.9 , Issue.SUPPL. 6
    • Nagle, P.C.1    Lugo, T.F.2    Nicita, C.A.3
  • 5
    • 25844463410 scopus 로고    scopus 로고
    • Adverse reactions to biologic agents: Focus on autoimmune disease therapies
    • DOI 10.1016/j.jaci.2005.03.028, PII S0091674905006056
    • Lee S.J, Kavanaugh A.: Adverse reactions to biologic agents: Focus on autoimmune disease therapies. J. Allergy Clin. Immunol., 2005;116:900-5. (Pubitemid 41400558)
    • (2005) Journal of Allergy and Clinical Immunology , vol.116 , Issue.4 , pp. 900-905
    • Lee, S.J.1    Kavanaugh, A.2
  • 6
    • 33745786806 scopus 로고    scopus 로고
    • Adverse side-effects to biological agents
    • Pichler W. J.: Adverse side-effects to biological agents. Allergy, 2006; 61, 8: 912-920.
    • (2006) Allergy , vol.61 , Issue.8 , pp. 912-920
    • Pichler, W.J.1
  • 7
    • 84882124318 scopus 로고    scopus 로고
    • Adverse Side Effects to Biological Agents
    • Pichler W.J. (ed.): Basel, Karger
    • Pichler J.W., Campi P.: Adverse Side Effects to Biological Agents. - in - Pichler W.J. (ed.): Drug Hypersensitivity. Basel, Karger, 2007, 151-165.
    • (2007) Drug Hypersensitivity , pp. 151-165
    • Pichler, J.W.1    Campi, P.2
  • 9
    • 84863742845 scopus 로고    scopus 로고
    • Ranibizumab (Lucentis) w leczeniu neowaskularnej (wysiekowej) postaci zwyrodnienia plamki zwia̧zanego z wiekiem (AMD): Dowody uzyskane z badań klinicznych
    • doi: 10.1136/bjo.2009.159160
    • Mitchell P., Korobelnik P., Lanzetta P. et al.: Ranibizumab (Lucentis) w leczeniu neowaskularnej (wysiekowej) postaci zwyrodnienia plamki zwia̧zanego z wiekiem (AMD): dowody uzyskane z badań klinicznych. BJO, 2009; doi: 10.1136/bjo.2009.159160.
    • (2009) BJO
    • Mitchell, P.1    Korobelnik, P.2    Lanzetta, P.3
  • 10
    • 34247276688 scopus 로고    scopus 로고
    • Zastosowanie leków biologicznych w dermatologii
    • Pełka M., Broniarczyk-Dyła G.: Zastosowanie leków biologicznych w dermatologii. Post. Dermatol. Alergol., 2007; 24/1:35-41.
    • (2007) Post. Dermatol. Alergol. , vol.24 , Issue.1 , pp. 35-41
    • Pełka, M.1    Broniarczyk-Dyła, G.2
  • 11
    • 11944253597 scopus 로고    scopus 로고
    • Biological agents in rheumatoid arthritis
    • Shankar S., Handa R.: Biological agents in rheumatoid arthritis. J. Postgrad. Med., 2004; 50: 293-299. (Pubitemid 40101229)
    • (2004) Journal of Postgraduate Medicine , vol.50 , Issue.4 , pp. 293-299
    • Shankar, S.1    Handa, R.2
  • 12
    • 77956985320 scopus 로고    scopus 로고
    • The loss of health status in rheumatoid arthritis and the effect of biologic therapy: A longitudinal observational study
    • Wolfe F., Michaud K.: The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study. Arthr. Res. Ther., 2010; 12: R35.
    • (2010) Arthr. Res. Ther. , vol.12
    • Wolfe, F.1    Michaud, K.2
  • 13
    • 84863767743 scopus 로고    scopus 로고
    • http://www.upmccancercenters.com/cainformation/biologictherapy.html
  • 14
    • 84863749285 scopus 로고    scopus 로고
    • http://www.imshealth.com
  • 15
    • 0034529448 scopus 로고    scopus 로고
    • Immunological principles of adverse drug reactions: The initiation and propagation of immune responses elicited by drug treatment
    • Naisbitt D.J., Gordon S.F., Pirmohamed M. et al.: Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf., 2000; 23: 483-507. (Pubitemid 32001512)
    • (2000) Drug Safety , vol.23 , Issue.6 , pp. 483-507
    • Naisbitt, D.J.1    Gordon, S.F.2    Pirmohamed, M.3    Park, B.K.4
  • 16
    • 34447299908 scopus 로고    scopus 로고
    • The spectrum and types of adverse side effects to biological immune modulators: A proposal for new classification
    • Zemkova M., Jebavy L., Kotlarova J. et al.: The spectrum and types of adverse side effects to biological immune modulators: a proposal for new classification. Folia Biologica (Praha), 2007; (53): 146-155. (Pubitemid 47054484)
    • (2007) Folia Biologica , vol.53 , Issue.4 , pp. 146-155
    • Zemkova, M.1    Jebavy, L.2    Kotlarova, J.3    Vlcek, J.4    Meyboom, R.H.B.5
  • 17
    • 77953563408 scopus 로고    scopus 로고
    • The complex clinical picture of side effects to biologicals
    • Hausmann O.V., Seitz M., Villiger P.M. et al.: The complex clinical picture of side effects to biologicals. Med. Clin. North Am., 2010; 94: 791-804.
    • (2010) Med. Clin. North Am. , vol.94 , pp. 791-804
    • Hausmann, O.V.1    Seitz, M.2    Villiger, P.M.3
  • 18
    • 79955573063 scopus 로고    scopus 로고
    • Immediate adverse reactions to biological: From pathogenic mechanisms to prophylactic management
    • Vultaggio A., Maggi E., Matucci A.: Immediate adverse reactions to biological: from pathogenic mechanisms to prophylactic management. Curr. Opin. Clin. Immunol., 2011; 11: 262-268.
    • (2011) Curr. Opin. Clin. Immunol. , vol.11 , pp. 262-268
    • Vultaggio, A.1    Maggi, E.2    Matucci, A.3
  • 19
    • 0029859871 scopus 로고    scopus 로고
    • Type 1, and Type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
    • Lucey D.R., Clerici M., Shearer G.M.: Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev., 1996; 9:532-562. (Pubitemid 26366537)
    • (1996) Clinical Microbiology Reviews , vol.9 , Issue.4 , pp. 532-562
    • Lucey, D.R.1    Clerici, M.2    Shearer, G.M.3
  • 20
    • 72149112759 scopus 로고    scopus 로고
    • Autoimmune diseases induced by biological agents. A double-edged sword?
    • Ramos-Casals M., Perez-Alvarez R., Diaz-Lagares C. et al.: Autoimmune diseases induced by biological agents. A double-edged sword? Autoimm. Rev., 2010 (9); 188-193.
    • (2010) Autoimm. Rev. , Issue.9 , pp. 188-193
    • Ramos-Casals, M.1    Perez-Alvarez, R.2    Diaz-Lagares, C.3
  • 22
    • 77956334120 scopus 로고    scopus 로고
    • Mapping the safety profile of biological. A disproportionality analysis using the WHO adverse drug reaction database, VigiBase
    • Giezen T.J., Mantel-Teeuwisse A.K., Meyboom R.H.B. et al.: Mapping the safety profile of biological. A disproportionality analysis using the WHO adverse drug reaction database, VigiBase. Drug Saf., 2010; 33 (10): 865-878.
    • (2010) Drug Saf. , vol.33 , Issue.10 , pp. 865-878
    • Giezen, T.J.1    Mantel-Teeuwisse, A.K.2    Meyboom, R.H.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.